Amy Lim, MD
Urology · Medford, ORNPI 1639514979
Payments from drug & device makers
Across 41 payments — averaging $53.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$1K
- Ferring Pharmaceuticals Inc.$245
- EDAP Technomed Inc$98
- Boston Scientific$90
- Coloplast$80
- Merck$66
- plus $473 from 17 others
What the payments were for
- Travel & lodging$90642%
- Food & beverage$1,26758%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 6 | $1,125 |
| Ferring Pharmaceuticals Inc. | 2 | $245 |
| EDAP Technomed Inc | 1 | $98 |
| Boston Scientific | 4 | $90 |
| Coloplast | 5 | $80 |
| Merck | 2 | $66 |
| Bluewind Medical | 1 | $60 |
| Johnson & Johnson | 2 | $59 |
| 180 Medical, Inc. | 2 | $56 |
| AbbVie | 2 | $48 |
| Urogen Pharma, Inc. | 2 | $36 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $29 |
| Myovant Sciences Inc. | 1 | $25 |
| Novartis | 1 | $25 |
| Innovation Technologies Inc | 1 | $23 |
| Teleflex LLC | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Recordati_rare_diseases_inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Profound Medical Corp. | 1 | $15 |
| Cook Medical LLC | 1 | $15 |
| Axonics, Inc. | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AQUABEAM SYSTEM$999
How this compares
$2,177 in reported general payments places this provider in the 50th percentile of 153 urology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 225 | $3,467 |
| Methenamine Hippurate | 49 | $3,463 |
| Trospium Chloride | 48 | $1,861 |
| Oxybutynin Chloride ErOxybutynin Chloride | 111 | $1,815 |
| Finasteride | 65 | $1,001 |
| Estradiol | 14 | $861 |
| Potassium Chloride | 11 | $407 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $196 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 35 | $128 |
| Ciprofloxacin Hcl | 27 | $82 |
Paid to pharmacies, not to this prescriber.
Other urology in Medford
- Kim ThaiMedford$57K
- Eric MartinMedford$9K
- Patrick DavolMedford$5K
- Thong BuiMedford$3K
- James LoosMedford$3K
- Bryan MehlhaffSpringfield$10.4M
- Mark GarzottoPortland$2.3M
- Lance MarrPortland$323K
- Ryan KoppPortland$266K
- Jen-Jane LiuPortland$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.